Ambrx Biopharma Inc (AMAM)

[Go-Gold]

Question, does locking up our shares do anything?

[Hercules1]

Fast Track designation can be requested with nonclinical data and/or preliminary clinical evidence.


they will request a fast track status.

and they have 2 phases of clinical trials done.

drug is safe and effective. critically needed.
100% disease control.

zero side effects.

so they do not need phase 3 clinical trials.

company is also siting on a ton of cash.

this stock can hit $20 in a matter of just a few days.

-------------------------------------------------------









In the Phase 2 ACE-Breast-03 study, which took place in the U.S., Korea, and Australia, the drug was assessed as a treatment for HER2-positive mBC (metastatic breast cancer) patients who are resistant or refractory to T-DM1.

The preliminary results showed a 51.7% overall response rate (ORR) and 100% disease control rate (DCR) following treatment with ARX788. Additionally, no drug-related serious adverse events (SAEs) were noted by any patients.

With investors reacting the way they did, it’s safe to say they were impressed with the results; considering how big the breast cancer market is, the drug’s potential has caused a bit of a stir.

[surf1944]

This is not a short term play, most P-II trials never move to P-III, even if it does it will be 7-10 years prior to anything coming to market, what to look for is in the coming months does a large pharma company invest in the product or the company. Any drug that is brought to market will costs 100's of millions of dollars to push it forward, AMAM may need to sell shares for years to come, the company will burn through cash at a increasingly rapid rate, again not a short term play. The next big event could very well be the selling of additional shares to take advantage of the higher share price.

[Go-Gold]

Oversold

[Hercules1]

It went up over 1000 percent for a reason:

They have the drug.

They have the goods.

49.83 percent institutional ownership is a very strong vote of confidence.


This will go up another 1000 percent.

[Hercules1]

Yep.

It is moving right now in after hours trading.


This will gap up to around $3 or higher tomorrow.

Pre market will be good too in the morning.

Now it is game on:

Story unfolding is simply too big.

This can hit $4 tomorrow.

[IVANj]

Took 5k at 2 today… just a matter of time

[Livinggood1]

Huge shorting today simple institutions own half the company they will be attacking tmrw huge gaps on upside

[JsTrades]

Only lesson here is set stop losses

[Go-Gold]

Institutions are going to teach shorty a lesson! Stay tuned for some up side!

[surf1944]

Weighted-average ordinary shares used to compute net loss per share attributable
to ordinary shareholders basic and diluted 143,175,224

https://d18rn0p25nwr6d.cloudfront.net/CIK-0001836056/32711112-e4d0-4538-9df1-baf19fa33d29.pdf

[surf1944]

The 10 DMA is $1.28

[Hercules1]

$AMAM:

there is no question this is headed to $5 as early as friday or next week.

float is just 14 million shares.

there is strong institutional ownership also.

nearly 50% of the stock is in institutional hands:

that says it all. only morons are selling.

nobody is smarter than those fund managers. they have done their DD before they decided to spend millions buying this stock.

and 50% institutional ownership is the strongest vote of confidence there is.

[Livinggood1]

I have 100 percent confidence we are now heading up to 5 plus

[Hercules1]

it was well on its way when it hit $2.50.

then some group decided to flip it.

of course it is being shorted to death also.

but this news is too big:

they have a multi billion dollar drug:

and 100% disease control. it doesnt get any better than this:


The preliminary results showed a 51.7% overall response rate (ORR) and 100% disease control rate (DCR) following treatment with ARX788. Additionally, no drug-related serious adverse events (SAEs) were noted by any patients.

With investors reacting the way they did, it’s safe to say they were impressed with the results; considering how big the breast cancer market is, the drug’s potential has caused a bit of a stir.

[DK11]

Yes, this isn't done it will fly up and fast when it takes off.

[Hercules1]

$AMAM:

lets see a green close today.

i still think we will see $3 today.

either later before the close or in after hours trading.



-----------------------------------------------------------


again this news is simply too damn big.


The preliminary results showed a 51.7% overall response rate (ORR) and 100% disease control rate (DCR) following treatment with ARX788. Additionally, no drug-related serious adverse events (SAEs) were noted by any patients.

With investors reacting the way they did, it’s safe to say they were impressed with the results; considering how big the breast cancer market is, the drug’s potential has caused a bit of a stir.

[surf1944]

https://stockcharts.com/h-sc/ui?s=amam&p=D&yr=0&mn=6&dy=0&id=p38090673899

https://www.barchart.com/stocks/quotes/amam/technical-chart?plot=CANDLE&volume=total&data=DO&density=ML&pricesOn=1&asPctChange=0&logscale=0&indicators=ACCUM;SMA(20);SMA(50);SMA(100);SMA(200);CHKMF(20)&sym=CGRA&grid=1&height=210&studyheight=100

https://www.barchart.com/stocks/quotes/amam/opinion

Open gap at .50 may need to fill!

[Hercules1]

$AMAM:

potentially a multi billion dollar drug here folks:


we are probably looking at a $50 to $70 dollar stock in time here.



The preliminary results showed a 51.7% overall response rate (ORR) and 100% disease control rate (DCR) following treatment with ARX788. Additionally, no drug-related serious adverse events (SAEs) were noted by any patients.

With investors reacting the way they did, it’s safe to say they were impressed with the results; considering how big the breast cancer market is, the drug’s potential has caused a bit of a stir.

[Hercules1]

$AMAM:

this is too cheap given these results:

market is massive:


The preliminary results showed a 51.7% overall response rate (ORR) and 100% disease control rate (DCR) following treatment with ARX788. Additionally, no drug-related serious adverse events (SAEs) were noted by any patients.

With investors reacting the way they did, it’s safe to say they were impressed with the results; considering how big the breast cancer market is, the drug’s potential has caused a bit of a stir.

[JsTrades]

Idk yet might want lower

[Hercules1]

$AMAM:

i think this is the bottom.

it should start climbing now.

i added a few more also.

looking for $3 here today or in after hours trading.

[Hercules1]

$AMAM:

$3 close quite possible here.


this is a good dip buy opportunity.

i grabbed a few more.

[JsTrades]

Added 2.25

[Livinggood1]

Loading will rocket out of this range

[axelvento]

Two Phase 3 studies and one registration enabled Phase 2 study with ARX788 (ACE-Breast-02, ACE-Gastric-02, and ACE-Breast-08) conducted by Amrbrx’s partner, NovoCodex Biopharmaceuticals, are ongoing in China with projected readouts in 2023.

[MT101]

Non stop beat down all day

[Livinggood1]

Undervalued here big time

[Livinggood1]

I'm in here for 10k holding for at least 5>7 plus

[Hercules1]

Load and hold folks.

This is at $10 next week if not this week.

[Hercules1]

This is going green today.

[MT101]

Agreed. But I think a lot sooner than a year

[Hercules1]

$AMAM:

100% disease control is simply massive.

we are looking at a $50 dollar stock here.


1 year price target is $50 to $60.

[MT101]

57% success rates during trial phase is huge! This is potentially the official cure for breast cancer. Thought I’d never see this in my lifetime. Truly incredible. This stock should be $100+. Curing breast cancer is priceless. Cheers to all that held their shares!

[axelvento]

and 100% disease control rate (DCR) !!!!!!!!!!! huge

[Sibware]

AMAM:Just noticed AMAM is on IHUB now.Great news last Friday for those who saw it early

[MT101]

Monday we fly! Multiple successful trials, this is potentially the cure for breast cancer! Only shorts coming in here are retail shorts, HF shorts won’t touch this, we watched them all get roasted Friday, one short posted on Twitter he lost $30k Friday trying to short this! Burning shorts is a huge win and I couldn’t be happier!

[MT101]

Looks like your about to blow your entire short position. Don’t be this guy that tried shorting AMAM Friday and lost $30k..

Not fun to post this one.... $AMAM destroyed me. Huge size, halted up twice couldn't get out. Not all fun and games sports fans. Back at it Monday. Went from +$30k to -$10k on the month. Luckily, I can handle that. 💀 pic.twitter.com/EMhjH8oy57

— Drysdale (@traderdrysdale) December 9, 2022

[droopyeyes]

Looks like a pump and dump

imo

[MT101]

Agreed, this is potentially the cure for breast cancer. We could just see a massive parabolic move next week to $100 if we get any more news. This is $HKD 2.0 loaded and holding

[TheFinalCD]

https://finance.yahoo.com/news/joint-press-release-settlement-between-130000487.html

https://finviz.com/quote.ashx?t=AMAM&p=d

JUST WOW

[TheFinalCD]

6500 shares

6500 dollars?

[BeamMeUpScotty]

Someone said that they were making a presentation after hours anyone know if that is correct or have the details?

[amitgupta]

Loaded 6500 before close , hoping for big jump, who cares if dips, drug is very promising, will above $10 easy
We may see More news next week.

[forgetaboutit1]

Sell time just passed

[amitgupta]

Loaded 6500 before close , hoping for big jump, who cares if dips, drug is very promising, will above $10 easy

[amitgupta]

Tragte $10 easy , this can go much higher based on drug data.FDA can rush for Phase III Open level, drug is great, no toxicity found, they can treat millions of people .

AVentis or Astra may swallow them or make a deal with them

[bcapps66]

Yeah...but what's happened since then? Dilution? Or just savage shorting?

[Acme Investments]

Let's rub off on my investments!! Thanks in advance!! Lol!!

[makinezmoney]

$AMAM: Many thanks........ pretty good day here, right


Closed here at 4.53........... started the day at 0.45

Not to shabby.


Now we watch $TMNA go from 0.70 to min target of $7

GO $AMAM